Position in XENE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$27,549,083
+$14,357,127 QoQ
Shares Held
473,759
+61.0% QoQ
Ownership
0.490%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 94.53604047627591.ToString("F0")%
Shared 0.ToString("F0")%
None 5.463959523724088.ToString("F0")%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. XENE ranks #79 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in XENE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,549,083 | 473,759 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $13,191,956 | 294,332 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $14,717,862 | 366,572 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $12,131,752 | 387,596 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $4,344,419 | 129,491 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,668,027 | 68,062 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $9,446,513 | 239,942 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $9,309,714 | 238,772 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $16,625,863 | 386,199 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $10,370,268 | 225,147 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $8,305,829 | 243,145 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $7,913,135 | 205,536 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $8,696,286 | 242,981 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,475,119 | 88,134 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,720,111 | 158,452 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $30,361,346 | 998,072 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $44,026,025 | 1,440,171 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $27,243,903 | 872,084 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $622,443 | 40,736 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $979,410 | 52,600 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $88,766 | 4,959 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $37,819 | 2,459 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $27,221 | 2,459 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $31,337 | 2,499 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $61,746 | 5,445 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||